Sylvie Pollmann

Serum IgG antibodies to peptidylarginine deiminase 4 in rheumatoid arthritis and associations with disease severity

Eirik Hornes Halvorsen, Sylvie Pollmann, I-M Gilboe et al. · Annals of the Rheumatic Diseases · 2007 · 108 citations

Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-α blocking agents

Eirik Hornes Halvorsen, Espen A. Haavardsholm, Sylvie Pollmann et al. · Annals of the Rheumatic Diseases · 2008 · 58 citations

Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma

Hakan Köksal, Pierre Dillard, Sarah E. Josefsson et al. · Blood Advances · 2019 · 58 citations · Full text

Primary sequence, together with other factors, influence peptide deimination by peptidylarginine deiminase-4

Maria Stensland, Sylvie Pollmann, Øyvind Molberg et al. · Biological Chemistry · 2008 · 35 citations

Peptide Engineering, Molecular Biology, Peptide Science +20

Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy

Pierre Dillard, Hakan Köksal, Sólrún Melkorka Maggadóttir et al. · Molecular Therapy · 2020 · 26 citations · Full text